Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Fredun Pharmaceuticals Ltd

Your Vote -

Buy

25.00%

Hold

50.00%

Sell

25.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Demise

    20 Jun 2025, 7:08PM Intimation of demise of Mr. Nariman Medhora under Regulation 30 of SEBI (LODR) Reg, 2015
  • Fredun Pharma - Investors Presentation Issued By Fredun Pharmaceuticals Limited Stating Annual Review & Strategic Outlook For

    10 Jun 2025, 1:30PM INVESTORS PRESENTATION
  • Fredun Pharma - Investor Presentation Of Fredun Pharmaceuticals Limited

    10 Jun 2025, 11:49AM INVESTOR PRESENTATION OF FREDUN PHARMACEUTICALS LIMITED
  • Fredun Pharma Q4 net profit up 39.72% at Rs 7.07 cr

    2 Jun 2025, 9:20AM The company reported standalone net profit of Rs 7.07 crore for the quarter ended March 31, 2025 as compared to Rs 5.06 crore in the same period last
  • Fredun Pharma - Revised Outcome Of The Board Meeting Dated 30.05.2025

    31 May 2025, 8:32PM Revised Outcome of the Board Meeting dated 30.05.2025
  • Fredun Pharma - Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025

    31 May 2025, 7:59PM Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2025 along with Statement of Assets and Liabi
  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 May 2025, 1:26AM Press Release of Fredun Pharmaceuticals for Q4 and FY25 Robust Performance.
  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    31 May 2025, 1:13AM Intimation of re-appointment of Secretarial Auditor, Internal Auditor and Cost Auditor.
  • Fredun Pharma - Standalone And Consolidated Financial Results For The Period Ended On 31St March 2025.

    31 May 2025, 1:04AM Standalone and Consolidated Financial results for the period ended on 31st March 2025.
  • Fredun Pharma - Board Meeting Outcome for Outcome Of Board Meeting

    31 May 2025, 12:57AM To consider approve and adopt The Standalone and consolidated Audited Financial Results for the Quarter and Financial year ended March, 31 2025
  • Fredun Pharma - Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Friday, 30Th

    22 May 2025, 4:39PM Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consid
  • Fredun Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 4:20PM As of March 2025, 48.93% is owned by Indian Promoters and 51.07% by Public. <p align=justify> Top three Promoters holding highest number of shares of
  • Fredun Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Apr 2025, 6:22PM Certificate Pursuant to Regulation 74(5) of the SEBI (DP) Reg, 2018
  • Fredun Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    9 Apr 2025, 6:41PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    9 Apr 2025, 4:32PM The company has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines,valued between Rs.150 millio

Key fundamentals

Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 307.8076 226.9811 182.9008 120.825 82.7105
Liabilities 307.8076 226.9811 182.9008 120.825 82.7105
Equity 4.7217 4.6992 4.5323 4.4326 3.9896
Gross Profit 50.5345 37.9823 27.7774 13.7953 9.1395
Net Profit 20.8076 15.6234 10.8066 6.3353 2.0146
Cash From Operating Activities -28.8833 -0.4387 -14.4088 -2.3802 0.1699
NPM(%) 4.6 4.48 3.93 2.82 1.5
Revenue 451.7062 348.1562 274.6756 224.4595 133.8933
Expenses 401.1717 310.1739 246.8982 210.6642 124.7538
ROE(%) 15.89 11.93 8.25 4.84 1.53

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 885.00 5.90 29.20 473.95 301.39 0.57
Lotus Eye Hospital and Institute Ltd 71.00 -0.70 203.00 1727.03 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 23.67 -1.17 0.00 3585.88 -39.50 0.00
Astec Lifesciences Ltd 940.65 1.63 0.00 1628.44 -687.10 0.00

Company Info

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.

Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.

Read More

Parent Organisation

Fredun Pharmaceuticals Ltd.

Founded

08/06/1987

Managing Director

Dr.(Mrs.)Daulat N Medhora

NSE Symbol

FAQ

The current price of Fredun Pharmaceuticals Ltd is

The 52-week high for Fredun Pharmaceuticals Ltd is

The market capitalization of Fredun Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fredun Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fredun Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fredun Pharmaceuticals Ltd shares.

The CEO of Fredun Pharmaceuticals Ltd is Dr.(Mrs.)Daulat N Medhora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT